 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - TAKEDA PHARMACEUTICAL CO LTD
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-03-19 Purchase | 2018-03-21 9:42 pm | Myovant Sciences Ltd. | MYOV | Takeda Pharmaceuticals International AG TAKEDA PHARMACEUTICAL CO LTD Takeda A/S Takeda Europe Holdings B.V. Takeda Pharma A/S 10% Owner | 7,420,625 | $18.67 | $138,543,069 | 7,420,625 (Indirect Direct) | View |
| 2018-03-19 Sale | 2018-03-21 9:42 pm | Myovant Sciences Ltd. | MYOV | Takeda Pharmaceuticals International AG TAKEDA PHARMACEUTICAL CO LTD Takeda A/S Takeda Europe Holdings B.V. Takeda Pharma A/S 10% Owner | 7,420,625 | $18.67 | $138,543,069 | 7,420,625 (Indirect Direct) | View |
| 2019-10-08 Purchase | 2019-11-22 06:23 am | Ovid Therapeutics Inc. | OVID | TAKEDA PHARMACEUTICAL CO LTD MILLENNIUM PHARMACEUTICALS INC 10% Owner | 2,000,000 | $2.5 | $5,000,000 | 5,750,000 (Indirect) | View |
| 2020-06-01 Sale | 2020-06-03 06:08 am | Translate Bio Inc. | TBIO | Shire Human Genetic Therapies Inc. TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 213,867 | $19.81 | $4,237,024 | 6,865,078 (Direct) | View |
| 2020-06-03 Sale | 2020-06-05 09:52 am | Translate Bio Inc. | TBIO | Shire Human Genetic Therapies Inc. TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 40,086 | $19.75 | $791,699 | 6,824,992 (Direct) | View |
| 2020-06-30 Sale | 2020-06-30 8:24 pm | Translate Bio Inc. | TBIO | Shire Human Genetic Therapies Inc. TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 6,824,992 | $20.68 | $141,140,837 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-05-13 Conversion | 2019-05-13 7:52 pm | N/A N/A | Cortexyme Inc. | CRTX | Takeda Ventures Inc. TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals International AG Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 2,679,802 | $0 | 0 (Direct) | View |
| 2019-05-13 Conversion | 2019-05-13 7:52 pm | N/A N/A | Cortexyme Inc. | CRTX | Takeda Ventures Inc. TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals International AG Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 2,360,071 | $0 | 0 (Direct) | View |
| 2019-05-13 Conversion | 2019-05-13 7:52 pm | N/A N/A | Cortexyme Inc. | CRTX | Takeda Ventures Inc. TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals International AG Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 319,731 | $0 | 0 (Direct) | View |